期刊文献+

内蒙古少数民族地区宫颈癌的筛查方法研究 被引量:10

The value of HPV testing combining with acetic acid,iodine visual inspection in cervical cancer screening
在线阅读 下载PDF
导出
摘要 目的探讨内蒙古少数民族聚居区宫颈癌及癌前病变适宜的筛查方法。方法2009年4月-8月对内蒙古自治区鄂尔多斯、兴安盟、通辽三个地区的2958名年龄30~59岁的已婚妇女进行了宫颈癌筛查。取宫颈脱落细胞,做人乳头瘤病毒(HPV-HC2)检测;同时用醋酸着色及碘着色(VIA/VILI)肉眼观察的方法进行筛查。对HPV-HC2阳性或VIA/VILI肉眼观察异常或两者均异常者,行阴道镜检查,在可疑处取宫颈组织活检,必要时行颈管诊刮术(ECC);送组织病理学检查确诊。结果内蒙古鄂尔多斯、通辽、兴安盟三地区HPV总感染率为17.36%,中度及以上宫颈上皮内瘤样病变(≥CIN2)和宫颈癌的检出率为0.9%;应用HPV-HC2筛出阳性者最后确诊≥CIN2者27例,而用VIA/VILI仅确诊13例,漏诊14例。结论HPV检测结合醋酸、碘肉眼观察是宫颈癌筛查的有效方法。在内蒙等经济发展不均衡地区,可尝试采用HPV检测进行初筛,对HPV阳性患者用VIA+VILI或者细胞学筛查的方法进行分流的筛查策略,降低漏诊率,也相对降低HPV阳性患者阴道镜的转诊率。 Objective To evaluate the financial burden of cervical cancer and cervical intraepithelial neoplasia (CIN) in minorities of Inner Mongolia,and to investigate the appropriate screening measure for the areas.Methods In 2009,2 958 married women of 30~59 yrs from three areas of Inner Mongolia Autonomous Region were underwent cervical cancer screening.Each subject was requested to collect the cervical exfoliated cells for human papilloma virus(HPV) detection(HC2),and then was screened by visual inspection with acetic acid (VIA) and Lugol's iodine(VILI) for the visual inspection of the cervix.Direct biopsies under colposcopy were taken if any abnormalities were found by VIA+VILI or HPV positive,endocervical curettage (ECC) was conducted if necessary.Women with positive HPV test results were called back in two weeks,and were performed colposcopy examination.Direct biopsy was taken if any abnormal lesions were found.Pathological diagnoses were given by the experts of the Chinese Academy of Medical Sciences Cancer Institute.Results The total HPV infection prevalence was 17.36%,and the prevalence for CIN2+ and cervical cancer was 0.9%.There were totally 27 cases finally dignosed as ≥CIN2 screened by HPVHC2 method while by VIA+VILI method only 13 cases were diagnosed and 14 were misseddiagnosed.Conclusions HPV testing combining with acetic acid,iodine visual inspection is an effective method for cervical cancer screening.And it is recommended as the primary screening method for cervical cancer in inner Mongolia or other economic undeveloped areas in China,with respect to its high sensitivity and specificity.Moreover,visual inspection or cytology could be performed as the triage measure for a positive HPV test result,to help reduce the unnecessary rate for colposcopy examination and biopsies.
出处 《中国妇产科临床杂志》 2012年第1期15-17,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 人乳头瘤病毒检测 内蒙古地区 宫颈癌筛查 human papilloma virus(HPV) Inner Mongolia cervical cancer screening
  • 相关文献

参考文献6

  • 1乔友林.子宫颈癌预防研究的里程碑[J].基础医学与临床,2006,26(12):1293-1295. 被引量:22
  • 2赵方辉,胡尚英,王少明,陈凤,张询,章文华,潘秦镜,乔友林.高危型人乳头瘤病毒载量与子宫颈病变的关系[J].中华预防医学杂志,2009,43(7):565-570. 被引量:45
  • 3李连弟,陈育德.见:全国肿瘤防治研究办公室,中国恶性肿瘤死亡调查研究(1990-1992).北京:人民卫生出版社,2008:149,443.
  • 4Zhao FH, Lin MJ, Chen F, et al. Performance of high- risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population - based studies from China. Lancet Oncol, 2010, 11: 1160-1171.
  • 5Qiao YL, Sellors JW, Eder PS, et al. A new HPV- DNA test for cervical - cancer screening in developing regions: a cross- sectional study of clinical accuracy in rural China. Lancet Oncol, 2008, 9: 929-936.
  • 6屠铮,李静,赵超,宋丹,崔淑慧,章文华,乔友林,Belinson JL,魏丽惠.醋白肉眼观察试验在宫颈病变筛查中的价值[J].中国妇产科临床杂志,2007,8(2):90-92. 被引量:25

二级参考文献36

  • 1赵方辉,马俊飞,乔友林,戎寿德,李凌,章文华.人乳头状瘤病毒DNA载量与子宫颈病变的关系[J].中华流行病学杂志,2004,25(11):921-924. 被引量:48
  • 2任生达,米振国,马俊飞,张永贞,王素梅,孙立新,向喜娥,王全红,石菊芳,乔友林.适宜农村地区子宫颈癌筛查方法的研究[J].肿瘤研究与临床,2005,17(6):391-393. 被引量:21
  • 3Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer (Review). J Clin Pathol,2002,55 : 244-265.
  • 4Cogliano V, Baan R, Straif K, et al. Carcinogenicity of human papillomaviruses. Lancet Oncol,2005,6 : 204.
  • 5Einstein MH, Studentsov YY, Ho GY, et al. Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia. Int J Cancer,2007,120: 55-59.
  • 6Ho GY, Bierman R, Beardsley L, et al. Natural history of cervieovaginal papillomavirus infection in young women. N Engl J Med,1998,338 : 423-428.
  • 7Rousseau MC, Trevisan A, Villa L, et al. Viral load as a predictor of HR-HPV infection persistence among worsen in the Ludwig- McGill cohort study in Sao Paulo, Brazil [ EB/OL] . [2005-06- 08 ]. http ://www. mcgill, ca/cancerepi/publications/2001/.
  • 8Sun CA, Liu JF, Wu DM, et al. Viral load of high-risk human papiUomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet,2002,76 : 41-47.
  • 9Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN 3 or cervical cancer. Lancet,2002, 360 : 228-229.
  • 10Moberg M, Gustavsson I, Wilander E, et al. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer,2005,92: 891-894.

共引文献88

同被引文献78

  • 1乔友林 章文华 赵方辉etal.子宫颈癌筛查及早诊早治[J].中国肿瘤,2000,9(9):541-541.
  • 2Hoory T,Monie AGravitt Pet al. Molecular epidemiol-ogy of human papillomavirus[J]. J Formos Med Assoc,2008,107(3).:198-217.
  • 3Zhao FH, Lin MJ, Chen F,et al. Papillomavirus DNAtesting as a primary screen for cervical cancer:a pooled a-nalysis of individual patient data from 17 population-based studies from China [ J], Lancet Oncol, 2010,11(12).:1160-1171.
  • 4de Sanjose S Diaz M, Castellsague X, et al. Worldwideprevalence and genotype distribution of cervical humanpapillomavirus DNA in women with normal cytology: ameta-analysis[J]. Lancet Infect Dis 2007,7 ( 7).: 453-459.
  • 5Li LD, Lu FZ, Zhang SW, Zhang SW, Mu R, Sun SD, Huangpu XM, Sun J, Zhou YS, Ouyang NH, Rao KQ, Chen YD, et al. Cancer mortality trends in the People's Republic of China: 1973 -1992. Chinese J Oneol 1997,19:3 -9.
  • 6Davey DD, Nielsen ML , Rosenstock W , et al. Tepmionlogy and specinmen adequacy in cervicovaginal cytoulogy: the college of American pathologists interlaboratory comparison program experience[J]. Arch Pathol Lab Med, 1992,116 : 903 - 907.
  • 7I Zur H. Papillomavirus infectiona major cause of hunmn canc- ers[J]. Biochem Biophys Acta,1996,1288(2) :55 -88.
  • 8Smith J S , Lindsay L , Hoot s B , et al. Human papillo- mavirus typedist ribution in invasive cervical cancer and high - grade cervical lesions :A meta - analysis update [ J ] . Int J Cancer, 2007 , 121(3) :621 - 632.
  • 9Monsonego J. Cervical cancer prevention : t he impact of HPVvaccination[ J ] . Gynecol Obstet Fertil , 2006,34 (3) :189 -201.
  • 10Allan BR , Marais DI Denny L , et al. The agreement be- tween cervical abnormalities ident - ified by cytology and detection of high - risk types of human papillomavirus [J]. S Mr Med J ,2006,96(11) :1186.

引证文献10

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部